Perform Another (Advanced) Search

1.  CenterWatch: New Medical Therapies in Disease Category (12), Angina
...CenterWatch: New Medical Therapies in Disease Category (12), Angina Angina Patient Medical Areas • Cardiology/Vascular Diseases September 3, 2007 Cardium reported mixed results from two ...
View Page

2.  CenterWatch: Clinical Trials in Category (12) Angina
...CenterWatch: Clinical Trials in Category (12) Angina Angina State • New York • North Carolina • Oklahoma • Texas Country • [X]   China New York New York : The ...
View Page

3.  Study Posting (1674) Trial #26612, Angina, Oklahoma City, OK
...Study Posting (1674) Trial #26612, Angina, Oklahoma City, OK Trial Information Seeking Oklahomans who have been diagnosed with chronic or unstable angina. Angina pectoris is the medical term for chest pain due to coronary heart disease. It ...
View Page

4.  Study Posting (5193) Trial #155653, Angina, Houston, TX
...Study Posting (5193) Trial #155653, Angina, Houston, TX Trial Information Angina Pectoris - Houston, TX This study is to determine the safety and effectiveness of a medication ...
View Page

5.  Study Posting (4519) Trial #122855, Angina, Shanghai, China
...Study Posting (4519) Trial #122855, Angina, Shanghai, China Trial Information A Study of Dilatrend (Carvedilol) in the Treatment of Patients With Chronic Stable Angina Pectoris Status: Completed Protocol Number: ML18030 Sponsor: Shanghai Roche Pharmaceuticals Ltd. Company Division: Pharmaceutical Official ...
View Page

6.  Study Posting (4519) Trial #122841, Angina, Beijing, China
...Study Posting (4519) Trial #122841, Angina, Beijing, China Trial Information A Study of Dilatrend (Carvedilol) in the Treatment of Patients With Chronic Stable Angina Pectoris Status: Completed Protocol Number: ML18030 Sponsor: Shanghai Roche Pharmaceuticals Ltd. Company Division: Pharmaceutical Official ...
View Page

7. Clinical Trial Results: Angina Pectoris
...Clinical Trial Results: Angina Pectoris Clinical Trial Results: Angina Pectoris Product Name: Dilatrend [carvedilol] Date of Report: 4/1/2006 Phase: III An open ...
View Page

8.  Study Posting (5242) Trial #160905, Angina, Raleigh, NC
...Study Posting (5242) Trial #160905, Angina, Raleigh, NC Trial Information HEART DISEASE: Volunteers needed for Cardiovascular Study Volunteers for this cardiovascular ...
...symptoms caused by blocked or narrowing arteries in the heart, which may lead to unstable angina (chest pain) or a heart attack. <strong.Patient Compensation: $35 for each completed visit There ...
View Page

9.  Newly Approved Drug Therapies (892) Ranexa (ranolazine), CV Therapeutics,
...Drug Name: Ranexa (ranolazine) Company: CV Therapeutics Approval Status: Approved January 2006 Treatment Area: Chronic Angina General Information Ranexa (ranolazine) is an orally-available, extended release anti-ischemic/anti-anginal drug ...
...reducing heart rate or blood pressure. Ranexa is specifically indicated for the treatment of chronic angina in patients who have failed to respond to prior angina therapy. It is contraindicated in ...
View Page

10.  Newly Approved Drug Therapies (847) Caduet (amlodipine/atorvastatin ), Pfizer,
...Drug Name: Caduet (amlodipine/atorvastatin ) Company: Pfizer Approval Status: Approved January 2004 Treatment Area: Hypertension/Angina General Information Caduet combines the drugs amlodipine (Norvasc, Lotrel) and atorvastatin (Lipitor), two widely prescribed ...
...blood pressure and high cholesterol. It is indicated for the treatment of hypertension, chronic stable angina and vasospastic angina (Prinzmetal’s or variant angina). It is also indicated for primary dysbetalipoproteinemia ...
View Page

11.  Newly Approved Drug Therapies (659) Angiomax (bivalirudin), The Medicines Company,
...a thrombin-specific anticoagulant to be used in conjunction with aspirin in patients with unstable angina undergoing percutaneous transluminal coronary angioplasty (PTCA). It is available by prescription only in a 250mg ...
...Clinical Results Double-blinded clinical trials involving 4,312 patients undergoing PTCA for new onset angina, accelerating episodes of angina, or angina at rest were conducted to test the effectiveness and ...
View Page

12.  Newly Approved Drug Therapies (44) Covera-HS (verapamil), G.D. Searle, Alza,
...HS (verapamil) Company: G.D. Searle, Alza Approval Status: Approved January 1996 Treatment Area: hypertension, angina General Information Covera-HS is a once-daily controlled release calcium channel blocker for the treatment of hypertension and angina. Covera-HS incorporates ALZA's controlled onset, extended release delivery system. The delivery system consists ...
View Page

13.  Newly Approved Drug Therapies (403) Tiazac (diltiazem hydrochloride), Forest Laboratories,
...Tiazac (diltiazem hydrochloride) Company: Forest Laboratories Approval Status: Approved February 1998 Treatment Area: chronic stable angina General Information Tiazac (diltiazem HCl) has been approved for the treatment of chronic stable angina. Tiazac was previously approved for the treatment of hypertension. Tiazac, a once-daily calcium channel ...
View Page

14.  Study Posting (96) Trial #160057, Angina, New York, NY
...Study Posting (96) Trial #160057, Angina, New York, NY Trial Information Vitamin D3 Repletion on Small LDL Vitamin D is a ...
...Rockefeller University Hospital support@centerwatch.com rucares@rockefeller.edu Vitamin D3 Repletion on Small LDL Angina New York, NY 160057 Clinical Trial Participation If you would like to learn more about ...
View Page

15. Clinical Trial Results by Drug Names
...study to assess efficacy and safety of carvedilol versus metoprolol in patients with chronic stable angina pectoris. Fast Facts: Protocol number: ML18030 Sponsor: Shanghai Roche Pharmaceutical Ltd Company division: Pharmaceutical Product name: Dilatrend Generic name: carvedilol Phase of development: III Therapeutic area, approved indication: Angina Pectoris Date of report: 4/1/2006 Clinical study summary: This trial was prematurely terminated ...
View Page

16.  Newly Approved Drug Therapies (1025) Toprol-XL (metoprolol succinate), AstraZeneca,
...Name: Toprol-XL (metoprolol succinate) Company: AstraZeneca Approval Status: Approved January 1995 Treatment Area: hypertension, angina pectoris and heart failure General Information Toprol-XL is a beta1-selective (cardioselective) adrenoceptor blocking ...
...effect leading to reduced sympathetic outflow to the periphery; and (3) suppression of renin activity. Angina pectoris Metoprolol blocks the catecholamine-induced increases in heart rate, velocity and extent of myocardial ...
View Page

17.  Newly Approved Drug Therapies (399) Tiazac (diltiazem hydrochloride), Forest Laboratories,
...Tiazac (diltiazem hydrochloride) Company: Forest Laboratories Approval Status: Approved February 1998 Treatment Area: chronic stable angina General Information Tiazac has been approved for use in the treatment of chronic stable angina. Tiazac was previously approved for the treatment of hypertension. Clinical Results Tiazac has been shown ...
View Page

18.  CenterWatch New Medical Therapies™ in Cardiology/Vascular Diseases
...CenterWatch New Medical Therapies™ in Cardiology/Vascular Diseases Cardiology/Vascular Diseases Aging Angina Atherosclerosis Atrial Fibrillation Blood Clots Cardiac Ischemia Cardiac Surgery Cardiovascular Abnormalities Claudication Collagen Vascular Diseases ...
View Page

19.  CenterWatch: Clincial Trial Listings in Cardiology/Vascular Diseases
...Listings in Cardiology/Vascular Diseases Clinical Trials in Cardiology/Vascular Diseases Aging   (9, 7 New! ) Angina   (6) Atherosclerosis   (9, 1 New! ) Atrial Fibrillation   (293, 1 New! ) Blood Clots   (1) Cardiac Surgery ...
View Page

20. Clinical Trial Results by Medical Conditions
...Results by Medical Conditions " /> " /> Clinical Trial Results by Medical Conditions • Alzheimer Disease (3) • Anemia (89) • Angina Pectoris (1) • Anxiety Disorders (1) • Asthma (1) • Atopic Dermatitis (1) • Atrial Fibrillation (1) • Bladder Cancer ...
View Page